Schizophrenia, epilepsy, cancer, methionine, and folate metabolism. Pathogenesis of schizophrenia

Cancer mortality in the elderly in 11 countries worldwide, 1970-2015.

Annals of oncology : official journal of the European Society for Medical Oncology·2019

Emerging Roles of Epigenetic Regulator Sin3 in Cancer.

Advances in cancer research·2016

Downregulation of Mcl-1 through GSK-3β activation contributes to arsenic trioxide-induced apoptosis in acute myeloid leukemia cells.

Leukemia·2012

Fludarabine phosphate selectively inhibits growth and modifies the antigenic phenotype of human glioblastoma-multiforme cells expressing a multidrug resistance phenotype.

International journal of oncology·2011

Induction of erythroid differentiation is associated with inhibition of glycolysis and a decrease in fructose 2,6-bisphosphate levels.

International journal of oncology·2011

Legal aspects of men's genitourinary health.

International journal of impotence research·2009

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Lancet (London, England)·2026

No significant change in urinary sodium excretion within 48h after Roux-en-Y gastric bypass surgery: the weight LUSER study.

Annals of the Royal College of Surgeons of England·2026

Gut-liver axis and intestinal microbiota: Key targets of herbal medicines in treatment of MASLD/MASH.

Chinese herbal medicines·2026

Evaluating traditional Chinese medicine modulation of the gut microbiota-bile acid axis in metabolic and inflammatory diseases: mechanistic evidence and translational priorities.

Frontiers in microbiology·2026

Molecular mechanisms, crosstalk and therapeutic potential of novel acylation modifications in cardiovascular and cerebrovascular diseases.

Acta pharmaceutica Sinica. B·2026

Unraveling the pyroptosis-mitophagy axis: from molecular mechanisms to therapeutic opportunities.

Frontiers in immunology·2026

The Association Between Magnesium Depletion Score and Depression Among Men in Central Sudan: A Community-Based Cross-Sectional Study.

Health science reports·2026

Related Experiment Videos

Schizophrenia, epilepsy, cancer, methionine, and folate metabolism. Pathogenesis of schizophrenia

Related Concept Videos

Cancer mortality in the elderly in 11 countries worldwide, 1970-2015.

Emerging Roles of Epigenetic Regulator Sin3 in Cancer.

Downregulation of Mcl-1 through GSK-3β activation contributes to arsenic trioxide-induced apoptosis in acute myeloid leukemia cells.

Fludarabine phosphate selectively inhibits growth and modifies the antigenic phenotype of human glioblastoma-multiforme cells expressing a multidrug resistance phenotype.

Induction of erythroid differentiation is associated with inhibition of glycolysis and a decrease in fructose 2,6-bisphosphate levels.

Legal aspects of men's genitourinary health.

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

No significant change in urinary sodium excretion within 48h after Roux-en-Y gastric bypass surgery: the weight LUSER study.

Gut-liver axis and intestinal microbiota: Key targets of herbal medicines in treatment of MASLD/MASH.

Evaluating traditional Chinese medicine modulation of the gut microbiota-bile acid axis in metabolic and inflammatory diseases: mechanistic evidence and translational priorities.

Molecular mechanisms, crosstalk and therapeutic potential of novel acylation modifications in cardiovascular and cerebrovascular diseases.

Unraveling the pyroptosis-mitophagy axis: from molecular mechanisms to therapeutic opportunities.

The Association Between Magnesium Depletion Score and Depression Among Men in Central Sudan: A Community-Based Cross-Sectional Study.

Related Experiment Videos

Schizophrenia, epilepsy, cancer, methionine, and folate metabolism. Pathogenesis of schizophrenia

Related Concept Videos

Related Articles